@animalusa.bsky.social
Biotechnologist. Replace #animaltesting by human-based #NonAnimalMethods 🧪🧬🫁🧫
We need #HumanBasedResearch for human-relevant science.
We need #HumanBasedResearch for human-relevant science.
Stats 2024/2023 confirm mediocre results for animal research:
-10% FDA approvals of novel drugs (50/55)
+3% layoffs
⚠️about 25% (like Resmetirom for MASH) were granted accelerated approval and have yet to demonstrate confirmatory evidence of efficacy.
www.fiercebiotech.com/biotech/big-...
-10% FDA approvals of novel drugs (50/55)
+3% layoffs
⚠️about 25% (like Resmetirom for MASH) were granted accelerated approval and have yet to demonstrate confirmatory evidence of efficacy.
www.fiercebiotech.com/biotech/big-...
Big Pharma layoff rounds jump 281% in '24, but overall industry rates similar to '23
Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. | Overall, biopharma layoffs rose ever s...
www.fiercebiotech.com
January 7, 2025 at 5:51 AM
Stats 2024/2023 confirm mediocre results for animal research:
-10% FDA approvals of novel drugs (50/55)
+3% layoffs
⚠️about 25% (like Resmetirom for MASH) were granted accelerated approval and have yet to demonstrate confirmatory evidence of efficacy.
www.fiercebiotech.com/biotech/big-...
-10% FDA approvals of novel drugs (50/55)
+3% layoffs
⚠️about 25% (like Resmetirom for MASH) were granted accelerated approval and have yet to demonstrate confirmatory evidence of efficacy.
www.fiercebiotech.com/biotech/big-...